![Manuel Lopez-Figueroa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manuel Lopez-Figueroa
Directeur/Membre du Conseil chez
ORYZON GENOMICS S.A.
Profil
Manuel López-Figueroa, PhD, is a Managing Director at Bay City Capital and has been with the firm since 2001.
He specializes in evaluating investment opportunities with an emphasis on CNS.
In addition, Dr. López is the Scientific Liaison for the Pritzker Neuropsychiatric Disorders Research Consortium, a collaborative research enterprise comprised of a group of leaders in psychiatry, neuroscience, and genetics from Stanford University, University of Michigan, Cornell University, and the Universities of California at Davis and Irvine.
The consortium aims to discover the neurobiological and genetic determinants of mood disorders and schizophrenia with the goal to develop novel diagnostics and therapeutics.
Dr. López is responsible for planning and directing all aspects of the consortium including strategy, R&D, legal (IP & contracts) and financial, to facilitate the commercialization of discoveries to fund additional research.
Dr. López has over 15 years of experience in the field of neuroscience, has won numerous awards during his academic research career, and has published extensively.
He completed post-doctoral work at the University of Michigan and at the University of Copenhagen, Denmark.
Dr. López received a PhD in Medicine and Surgery, and a MS in Molecular and Cell Biology from the Universities of Las Palmas and La Laguna, Spain, respectively.
Postes actifs de Manuel Lopez-Figueroa
| Sociétés | Poste | Début |
|---|---|---|
| ORYZON GENOMICS S.A. | Directeur/Membre du Conseil | 11/05/2020 |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Consultant / Advisor | 07/07/2021 |
Imidomics, Inc.
 Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Directeur des opérations | 01/06/2015 |
Cantero Therapeutics, Inc. | Fondateur | 01/01/2018 |
Zulia Biotech, Inc. | Directeur/Membre du Conseil | - |
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel, and Australia. The firm targets companies operating in the field of health technology. It provides financing for pre-seed, seed, and early stage capital requirements with investment size ranging between EUR 0.2 million and EUR 1.5 million. It acts both as a lead and co-investor and also participates in subsequent investment rounds. | Consultant / Advisor | 01/01/2019 |
Formation de Manuel Lopez-Figueroa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Laguna University Of
 La Laguna University Of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Commercial Services |
Nina Capital SGEIC SA
Nina Capital SGEIC SA Investment ManagersFinance Nina Capital invests in companies located in Pan European, United Kingdom, United States, Canada, Israel, and Australia. The firm targets companies operating in the field of health technology. It provides financing for pre-seed, seed, and early stage capital requirements with investment size ranging between EUR 0.2 million and EUR 1.5 million. It acts both as a lead and co-investor and also participates in subsequent investment rounds. | Finance |
Cantero Therapeutics, Inc. | |
Zulia Biotech, Inc. |
